The second International Electronic Conference on Medicinal Chemistry, organized and sponsored by the publisher MDPI AG and the Journal Pharmaceuticals, took place in November 2016 on the SciForum website (www.sciforum.net/conference/ecmc-12). More than 150 authors from 22 countries participated in the event. Selected works presented during the scientific meeting are disclosed in this report.
Since the beginning of mankind, plants have been used as the source of medicinal agents, thereby becoming a major course to discovering new drugs. The practice of using traditional medicine is prevalent in Pakistan, that has a rich history of herbal plants being used by Hakims in folk medicine (Unani medicine). The Asteraceae family is the largest plant family in Pakistan, with plants of considerable medicinal importance. Endophytes include all organisms that symptomlessly colonize the living internal tissues of their hosts during a variable period of their lifetime. There they produce a broad variety of bioactive secondary metabolites with unique structures that are advantageous for the plant. Endophytic actinomycetes also colonize the internal tissues of plants without causing any visible changes or damage. They exploit an unusual habitat and considering this, this may enable them to possess the potential to produce bioactive compounds similar to those of their host plant. Our study explores the bioprospecting potential related to endophytic actinomycetes of Asteraceae medicinal plants of Pakistan. After isolation and identification the endophytes were screened for their bioactive metabolites potential for new drug targets. This included extensive biological and chemical screening. The bioactive compounds were purified through column chromatography and final identification was done through HPLC-MS and NMR. The purified compounds were observed to be extremely potent with promising antimicrobial potential against major pathogens including algae and fungal strains as well as possessing antioxidant and cytotoxic potential.
Sesquiterpene lactones constitute a large class of secondary plant metabolites, which bear α-methylene-γ-lactone groups as common structural element and display a number of bioactivities (Castellano, G., et al. Int. J. Mol. Sci., submitted for publication). Every year, 1-2 million people living in the tropics and subtropics die of malaria, the most infectious disease in the world today. The lactone artemisinin and its derivatives are currently the most effective treatments vs. malaria. Artemisinins are derived from extracts of sweet wormwood (Artemisia annua) and are well established for the treatment of malaria, particularly highly drug-resistant strains. They resulted in one of the most significant advances in the treatment of malaria since the discovery and first use of quinine over 300 years ago. Their efficacy also extends to phylogenetically unrelated parasitic infections, e.g., schistosomiasis. They showed potent and broad anticancer properties in cell lines and animal models. What hope does this drug offer for the future? Artemisinin and its derivatives present structures that differ different from the classical quinoline and contribute to the mechanism of action, whereby the pharmacophoric -O 1 -O 2 -peroxide linkage in the endoperoxide ring literally triggers artemisinin to explode. Artemisinin is poorly soluble in water (and oil). When creating the first generation of artemisinin derivative drugs in 1970s, the overriding goal was to improve its solubility characteristics, so that artemisinin derivatives be more easily formulated and efficiently delivered. Despite much research, artemisinin remains the only known natural product to contain a 1,2,4-trioxane ring and various Artemisia species continue to be the only known natural sources. Phytochemical investigation of these species revealed an abnormally wide range of other endoperoxides and hydroperoxides, many of which were not tested for their antimalarial activity. In this communication the design, synthesis and cytotoxicity of some novel dihydroartemisinin-coumarin hybrids produced via click chemistry are described. Sesquiterpene lactones constitute a large class of secondary plant metabolites, which bear α-methylene-γ-lactone groups as common structural element and display a number of bioactivities (Castellano, G., et al. Int. J. Mol. Sci., submitted for publication). Every year, 1-2 million people living in the tropics and subtropics die of malaria, the most infectious disease in the world today. The lactone artemisinin and its derivatives are currently the most effective treatments vs. malaria. Artemisinins are derived from extracts of sweet wormwood (Artemisia annua) and are well established for the treatment of malaria, particularly highly drug-resistant strains. They resulted in one of the most significant advances in the treatment of malaria since the discovery and first use of quinine over 300 years ago. Their efficacy also extends to phylogenetically unrelated parasitic infections, e.g., schistosomiasis. They showed potent and broad anticancer properties in cell lines and animal models. What hope does this drug offer for the future? Artemisinin and its derivatives present structures that differ different from the classical quinoline and contribute to the mechanism of action, whereby the pharmacophoric -O1-O2-peroxide linkage in the endoperoxide ring literally triggers artemisinin to explode. Artemisinin is poorly soluble in water (and oil). When creating the first generation of artemisinin derivative drugs in 1970s, the overriding goal was to improve its solubility characteristics, so that artemisinin derivatives be more easily formulated and efficiently delivered. Despite much research, artemisinin remains the only known natural product to contain a 1,2,4-trioxane ring and various Artemisia species continue to be the only known natural sources. Phytochemical investigation of these species revealed an abnormally wide range of other endoperoxides and hydroperoxides, many of which were not tested for their antimalarial activity. In this communication the design, synthesis and cytotoxicity of some novel dihydroartemisinin-coumarin hybrids produced via click chemistry are described.
Artemisinin: Tentative Mechanism of Action and Resistance (A008)
outbreaks of human and animal diseases, and WNV infection is now considered an emerging world health problem. Like other RNA viruses, WNV has a compact RNA genome that efficiently stores all the information required for the completion of the infectious cycle. The efficiency of this storage system is attributable to supracoding elements, i.e., discrete, structural units that play essential functions. The information coded in the form of structural elements overlaps and complements the protein coding information and is highly conserved across Flavivirus spp. These elements therefore offer interesting potential targets for novel therapeutic agents. We have applied a SELEX procedure to isolate RNA aptamers against the essential 3' untranslated region (3'UTR) of the WNV genome. Aptamers are oligonucleotides that efficiently and specifically bind to a ligand molecule. Starting from a theoretical highly sequence-variable population consisting of more than 10 18 different molecules, and after six rounds of selection we have identified two main groups of aptamers defined by conserved sequence motifs complementary to highly conserved counter parts within essential structural elements of the WNV genome. Current results point out the potential of these essential functional genomic RNA elements to efficiently bind RNA molecules, therefore to be involved in RNA-RNA interactions, offering a potential of being used as targets of antiviral agents based on nucleic acids. Further biochemical and functional studies are being performed to characterize the antiviral activity of identified RNA aptamers.
Antimicrobial Peptides (AMPs) represent one of the most durable and effective defences of multicellular organisms against bacterial infections. These cationic and amphipathic peptides represent promising leads for the development of antibiotics combatting the resistance of bacteria to antibiotics. However, their clinical applications have often been limited by an inadequate margin of safety (Zasloff, M. Nature 2002, 415, 389-395).
A prodrug approach can overcome a toxicity barrier in drug delivery. Prodrugs of AMPs can be generated by transiently reducing or annulling their net positive charges by attaching a negative promoiety through a linker which can be degraded by an enzyme (bacterial or human) confined to sites of infection. For example, neutrophil elastase (NE), a human protease involved in chronic airway inflammation and infections associated with cystic fibrosis (CF), can restore the cationic property of AMPs modified with oligo-glutamate promoieties. Consequently, their bactericidal activities against the CF pathogen P. aeruginosa are restored by NE in CF bronchoalveolar lavage fluids. The potential of this prodrug approach in reducing the safety barrier in the clinical use of AMPs has also been demonstrated in vivo, in a murine model of lung delivery (Forde, É., et al. Antimicrob Agents Chemother. 2016, 60, 2813-2821). Finally, an in vitro nebulisation study performed with a vibrating mesh nebuliser demonstrates that a high level of dosing in the lung can be achieved for this AMP prodrug. AMPs has also been demonstrated in vivo, in a murine model of lung delivery (Forde, É., et al. Antimicrob Agents Chemother. 2016, 60, 2813-2821). Finally, an in vitro nebulisation study performed with a vibrating mesh nebuliser demonstrates that a high level of dosing in the lung can be achieved for this AMP prodrug.
In parallel, a novel class of peptidomimetics with antimicrobial activities similar to AMPs, against Gram-positive bacteria, has been developed. Their spectrum of activity is currently extended to Gram-negative organisms.
Many sulfonamides with the general formula R−SO2NH2 constitute an important class of inhibitors of the zinc enzyme carbonic anhydrase (CA) used in antiglaucoma therapy. It is well established that a water-soluble sulfonamide, also possessing relatively balanced lipid solubility, would be an effective antiglaucoma drug via the topical route (Supuran, C.T., et al. Design of new aromatic sulfonamides was carried out using computational methods of theoretical medicinal chemistry as described in our previous works (Remko, M., et al. Bioorg. Med. Chem. 2004, 12, 5395-5403). Of particular interest are the molecular geometries of neutral and anionic species, acidities, and lipophilicities. Synthesis of designed new aromatic sulfonamides was conducted according to the procedures described in the references. Antiglaucoma activity of the designed compounds was evaluated in both in vitro and in vivo conditions. For determination of the intraocular pressure changes experiments with adult male chinchilla rodents were performed. In this contribution we present the design and synthesis of a novel drug-like aromatic sulfonamides of general formulas I and II with favorable biological, structural, physicochemical and some pharmacokinetic properties comparable to those obtained for the therapeutically useful
Many sulfonamides with the general formula R-SO 2 NH 2 constitute an important class of inhibitors of the zinc enzyme carbonic anhydrase (CA) used in antiglaucoma therapy. It is well established that a water-soluble sulfonamide, also possessing relatively balanced lipid solubility, would be an effective antiglaucoma drug via the topical route (Supuran, C.T., et al. Design of new aromatic sulfonamides was carried out using computational methods of theoretical medicinal chemistry as described in our previous works (Remko, M., et al. Bioorg. Med. Chem. 2004, 12, 5395-5403). Of particular interest are the molecular geometries of neutral and anionic species, acidities, and lipophilicities. Synthesis of designed new aromatic sulfonamides was conducted according to the procedures described in the references. Antiglaucoma activity of the designed compounds was evaluated in both in vitro and in vivo conditions. For determination of the intraocular pressure changes experiments with adult male chinchilla rodents were performed. In this contribution we present the design and synthesis of a novel drug-like aromatic sulfonamides of general formulas I and II with favorable biological, structural, physicochemical and some pharmacokinetic properties comparable to those obtained for the therapeutically useful acetazolamide, dorzolamide and brinzolamide. The solid-state structure of novel aromatic sulfonamides has been examined by X-ray crystallography. Theoretical medicinal chemistry methods were applied for structural characterization of these compounds in the gas phase and water solution. Of particular interest are the molecular geometries of neutral and anionic species, acidities, and lipophilicities. The data obtained allows us to assume that acetazolamide, dorzolamide and brinzolamide. The solid-state structure of novel aromatic sulfonamides has been examined by X-ray crystallography. Theoretical medicinal chemistry methods were applied for structural characterization of these compounds in the gas phase and water solution. Of particular interest are the molecular geometries of neutral and anionic species, acidities, and lipophilicities. Based on an earlier suggested general pharmacophore approach, compounds active against both tuberculosis virulent strain H37Rv and Staphylococcus aureus were obtained. The main drawback of these compounds was an almost complete CYP 3A4 inhibition, which presumably could be overcome by macrocyclization. Two 15-16-membered macrocyclic scaffolds C and D shown in the picture with pharmacophore groups located in appropriate positions were designed and synthetic schemes for their achievement were elaborated. 
D
Testing of these compounds against CYP450 enzymes confirmed generally lower inhibition of key cytochromes CYP 3A4 and CYP2D6 by suggested macrocyclic compounds compared to acyclic prototypes. New macrocyclic compounds retained the ability to inhibit Staphylococcus aureus growth. The best compound XI showed low CYP450 inhibition and significant (77.2%) inhibition of Staphylococcus aureus growth. Based on an earlier suggested general pharmacophore approach, compounds active against both tuberculosis virulent strain H37Rv and Staphylococcus aureus were obtained. The main drawback of these compounds was an almost complete CYP 3A4 inhibition, which presumably could be overcome by macrocyclization. Two 15-16-membered macrocyclic scaffolds C and D shown in the picture with pharmacophore groups located in appropriate positions were designed and synthetic schemes for their achievement were elaborated.
acetazolamide, dorzolamide and brinzolamide. The solid-state structure of novel aromatic sulfonamides has been examined by X-ray crystallography. Theoretical medicinal chemistry methods were applied for structural characterization of these compounds in the gas phase and water solution. Of particular interest are the molecular geometries of neutral and anionic species, acidities, and lipophilicities. The data obtained allows us to assume that new aromatic sulfonamides may represent a novel class of compounds in the search for new effective antiglaucoma drugs (Supuran, C. Based on an earlier suggested general pharmacophore approach, compounds active against both tuberculosis virulent strain H37Rv and Staphylococcus aureus were obtained. The main drawback of these compounds was an almost complete CYP 3A4 inhibition, which presumably could be overcome by macrocyclization. Two 15-16-membered macrocyclic scaffolds C and D shown in the picture with pharmacophore groups located in appropriate positions were designed and synthetic schemes for their achievement were elaborated. 
Testing of these compounds against CYP450 enzymes confirmed generally lower inhibition of key cytochromes CYP 3A4 and CYP2D6 by suggested macrocyclic compounds compared to acyclic prototypes. New macrocyclic compounds retained the ability to inhibit Staphylococcus aureus growth. The best compound XI showed low CYP450 inhibition and significant (77.2%) inhibition of Staphylococcus aureus growth.
Testing of these compounds against CYP450 enzymes confirmed generally lower inhibition of key cytochromes CYP 3A4 and CYP2D6 by suggested macrocyclic compounds compared to acyclic prototypes. New macrocyclic compounds retained the ability to inhibit Staphylococcus aureus growth. The best compound XI showed low CYP450 inhibition and significant (77.2%) inhibition of Staphylococcus aureus growth. In silico docking studies in P-gp rat model anticipated enantioselectivity for these new derivatives. The thioxanthones' cytotoxicity was evaluated by the Neutral Red uptake assay, in order to select a non-cytotoxic working concentration. The compounds were assessed for their influence in P-gp ATPase assay. The investigation of P-gp expression and activity allowed to discover new P-gp modulators. Nevertheless, no significant differences between enantiomeric pairs of thioxanthones were observed. 
Plasma Neurotransmitters Variation in Growth Hormone Deficient Children Under rh-GH Replacement Therapy. Preliminary Data (A015)
Ana-Maria Stefanescu *, Cristina Dumitrescu and Adriana Padure National Institute of Endocrinology "C. I. Parhon", Bucharest, Romania * Correspondence: stefanescuam@yahoo.com Aim: To evaluate the impact of rh-GH replacement therapy on neurotransmitters: gamma-amino butyric acid (GABA), dopamine (DA) and serotonin (5-HT) in growth hormone
In silico docking studies in P-gp rat model anticipated enantioselectivity for these new derivatives. The thioxanthones' cytotoxicity was evaluated by the Neutral Red uptake assay, in order to select a non-cytotoxic working concentration. The compounds were assessed for their influence in P-gp ATPase assay. The investigation of P-gp expression and activity allowed to discover new P-gp modulators. Nevertheless, no significant differences between enantiomeric pairs of thioxanthones were observed. 
Plasma Neurotransmitters Variation in Growth Hormone

Research design and methods:
This retrospective study included 30 subjects with growth hormone deficit clinically established: 20 boys (5-14 years) and 10 girls (6-14 years). All of them underwent GH replacement therapy from 9 months-10.6 years. rh-GH dose varied in all subjects from 0.6-1.9 mg/day based on detailed clinical and anthropometric data. In 2015, all subjects in different phases of treatment were tested for plasma: GABA, DA, 5-HT and IGF-1 Results: Median plasma GABA in boys vs. girls was: 50.5 vs. 46 ng/mL; median plasma DA in boys vs. girls was: 43.34 vs. 29.4 pg/mL; median 5-HT in boys vs. girls was: 227.5 vs. 208.7 ng/mL and median IGF-1 in boys vs. girls was: 334 vs. 357.25.7 ng/mL. We established a statistically significant difference in plasma GABA and in DA values in boys vs. girls. High multiple regression coefficients were established between age and IGF-1, DA, GABA or between IGF1 and 5-HT, DA, GABA in boys vs. girls
Conclusions: This study established a link between brain neurotransmitters and the height gain in GH-deficient children under replacement therapy in different phases of treatment. In our study, we evaluated this enzyme in plasma from pheochromocytoma subjects establishing correlations with some metabolites. Research design and methods: This retrospective study included 30 subjects with growth hormone deficit clinically established: 20 boys (5-14 years) and 10 girls (6-14 years). All of them underwent GH replacement therapy from 9 months-10.6 years. rh-GH dose varied in all subjects from 0.6-1.9 mg/day based on detailed clinical and anthropometric data. In 2015, all subjects in different phases of treatment were tested for plasma: GABA, DA, 5-HT and IGF-1.
Tyrosine Hydroxylase, the Rate-limiting Enzyme in Catecholamine Biosynthesis Could Be an Index of Functionality in Pheochromocytoma Diagnosis (A016)
Results: Median plasma GABA in boys vs. girls was: 50.5 vs. 46 ng/mL; median plasma DA in boys vs. girls was: 43.34 vs. 29.4 pg/mL; median 5-HT in boys vs. girls was: 227.5 vs. 208.7 ng/mL and median IGF-1 in boys vs. girls was: 334 vs. 357.25.7 ng/mL. We established a statistically significant difference in plasma GABA and in DA values in boys vs. girls. High multiple regression coefficients were established between age and IGF-1, DA, GABA or between IGF1 and 5-HT, DA, GABA in boys vs. girls.
Conclusions: This study established a link between brain neurotransmitters and the height gain in GH-deficient children under replacement therapy in different phases of treatment. In our study, we evaluated this enzyme in plasma from pheochromocytoma subjects establishing correlations with some metabolites. 
Research design and methods:
Conclusions: This study established a link between brain neurotransmitters and the height gain in GH-deficient children under replacement therapy in different phases of treatment. In our study, we evaluated this enzyme in plasma from pheochromocytoma subjects establishing correlations with some metabolites. values were done with our lab normal range Statistical analysis used multiple regression to evaluate relationship between TH and all three parameters: NMNp/MNp/CgA.
Tyrosine Hydroxylase, the Rate-limiting Enzyme in Catecholamine Biosynthesis Could Be an Index of Functionality in Pheochromocytoma Diagnosis (A016)
Results: All subjects showed excessive plasma NMNp (median: 1434 pg/mL); in seven cases there was an oversecretion of MNp (median: 441 pg/mL) and CgA was higher in nine cases (median: 668 ng/mL).TH was identified in all plasma samples with a median of: 2.08 ng/mL. Greater TH values were detected in cases with an overexcess of metabolites. Good correlations were established between NMNp/TH (0.51), MNp/TH(0.81)NMNp/CgA (0.71).
Conclusions: Metabolites detected in excess correlate well with TH values, proving a great rate of catecholamine synthesis in some cases. We could affirm TH could be used as an index of functionality in pheochromocytoma diagnosis.
TRP Modulators Based on Glycine and Mono-, Bicyclic Terpenoids-Synthesis and Pharmacological Properties (A017)
Mariia Nesterkina * and Iryna Kravchenko Department of Pharmaceutical Chemistry, Odessa National University, Odessa 65026, Ukraine * Correspondence: mashaneutron@gmail.com
Currently, significant interest in drug development is focused on obtaining drugs that simultaneously affect various pharmacological targets and thus exhibit combined actions. Herein we demonstrate the possibility of development of novel drugs that are able to simultaneously modulate TRP-channels and bind to glycine receptors. For this purpose esters based on mono-and bicyclic terpenoids (menthol, thymol, carvacrol, guaiacol, eugenol, borneol) and an inhibitory amino acid (glycine) were synthesized via Steglich esterification. Their anticonvulsant action was evaluated by a PTZ-induced convulsion model and analgesic effect-by pharmacological models of thermal and chemical stimuli. All studied esters were found to produce antinociceptive effects and attenuate acute pain more than the reference drug benzocaine after topical application. The present findings indicate that glycine esters of the abovementioned terpenoids are not classical prodrugs and possess their own pharmacological activity. Prolonged antiseizure action of the esters was revealed at 24 h after oral administration. Moreover, orally co-administered gidazepam (1 mg/kg) and glycine esters produce synergistic seizure prevention effects. Subjects and Methods: Ten subjects (nine women/one man aged 40-72 years) clinically suspected of pheochromocytoma, were biochemically investigated for free plasma normetanephrines(NMNp)/ metanephrines(MNp),plasma chromogranin A(CgA), plasmaTH. Comparison of tumoral metabolites values were done with our lab normal range Statistical analysis used multiple regression to evaluate relationship between TH and all three parameters: NMNp/MNp/CgA.
Mariia Nesterkina * and Iryna Kravchenko Department of Pharmaceutical Chemistry, Odessa National University, Odessa 65026, Ukraine * Correspondence: mashaneutron@gmail.com Currently, significant interest in drug development is focused on obtaining drugs that simultaneously affect various pharmacological targets and thus exhibit combined actions. Herein we demonstrate the possibility of development of novel drugs that are able to simultaneously modulate TRP-channels and bind to glycine receptors. For this purpose esters based on mono-and bicyclic terpenoids (menthol, thymol, carvacrol, guaiacol, eugenol, borneol) and an inhibitory amino acid (glycine) were synthesized via Steglich esterification. Their anticonvulsant action was evaluated by a PTZ-induced convulsion model and analgesic effect-by pharmacological models of thermal and chemical stimuli. All studied esters were found to produce antinociceptive effects and attenuate acute pain more than the reference drug benzocaine after topical application. The present findings indicate that glycine esters of the abovementioned terpenoids are not classical prodrugs and possess their own pharmacological activity. Prolonged antiseizure action of the esters was revealed at 24 h after oral administration. Moreover, orally co-administered gidazepam (1 mg/kg) and glycine esters produce synergistic seizure prevention effects. DHA displays an equatorial carboxylic group located at C18 while in other natural congeners the carboxylic group adopts the axial configuration (C19) as in 4-epidehydroabietic acid or callitrisic acid (2) . Recently, a series of related acids having a C19 carboxylic group have been isolated. For example, the jiadifenoic acids A-I. These have shown antiviral properties against Coxsackie virus. We have developed the synthesis of jiadifenoic acid C (3) from callitrisic acid isolated from Sandarac resin (González, M. A. et al. J. Nat. Prod. 2014, 77, 2114-2117). The ready availability of these acids from our work and the absence of their biological and pharmacological studies as well as chemical manipulation prompted us to carry out this research. In this communication, we report on the synthesis of several derivatives of callitrisic acid along with the results of the evaluation of their antiproliferative and modulating GABAA receptor activities. Human adenoviruses (HAdV) are ubiquitous infectious DNA viruses possessing a broad spectrum of pathogenicity. More than 60 HAdV serotypes have been identified that are responsible for different respiratory, gastrointestinal, and ocular diseases. HAdV are able to persist in humans for a long time in a latent state and can be reactivated by various factors. They cause grave problems in immunocompromised hosts by the development of generalized HAdV infection. The diseases caused by Herpes Simplex virus are widely distributed. Treatment of these infections is the most significant medical problem. However, the appearance of resistant virus is a current problem in the treatment of patients and deficiency in the antiviral preparations caused their toxicity. Therefore, it is very important to develop new antiviral drugs against this virus.
Nucleoside analogues have a special place among the most effective antiviral drugs. The study of fluorinated nucleoside sugars chemistry became the background for the development of promising chemotherapeutic agents with antitumor and antiviral effects. Compounds with modified heterocyclic core compared with the natural nucleoside analogues are now of interest. Our research has been related to the determination of cytotoxicity and antiviral activity regarding HSV-1, HSV-2 and HAdV5 of new fluorinated compounds possessing different chemical structures. Human adenoviruses (HAdV) are ubiquitous infectious DNA viruses possessing a broad spectrum of pathogenicity. More than 60 HAdV serotypes have been identified that are responsible for different respiratory, gastrointestinal, and ocular diseases. HAdV are able to persist in humans for a long time in a latent state and can be reactivated by various factors. They cause grave problems in immunocompromised hosts by the development of generalized HAdV infection. The diseases caused by Herpes Simplex virus are widely distributed. Treatment of these infections is the most significant medical problem. However, the appearance of resistant virus is a current problem in the treatment of patients and deficiency in the antiviral preparations caused their toxicity. Therefore, it is very important to develop new antiviral drugs against this virus.
Nucleoside analogues have a special place among the most effective antiviral drugs. The study of fluorinated nucleoside sugars chemistry became the background for the development of promising chemotherapeutic agents with antitumor and antiviral effects. Compounds with modified heterocyclic core compared with the natural nucleoside analogues are now of interest. Our research has been related to the determination of cytotoxicity and antiviral activity regarding HSV-1, HSV-2 and HAdV5 of new fluorinated compounds possessing different chemical structures.
Cytotoxicity of the compounds was determined by MTT-test or neutral red dye (NR) according to standard protocols. Antiviral effect was determined using PCR, MTT-test and cytomorphological methods.
Two compounds, G8 and 10S-23, inhibited the reproduction of all viruses with different efficiency. Compound G9 was active only in relation to both types of herpes. G26 suppressed reproduction of HSV-2/BH and HAdV5, whereas compounds 10S-20 and 10S-24 were active only in relation to reproduction HSV-1/US. According to the results obtained in the present study: antiviral activity of substances submitted to the post-treatments was demonstrated; the absence of antiviral activity of substances submitted to the pre-treatments, during absorption and penetration of the virus was shown; absence of virucidal activity of substances was shown. That data suggest that the substances may be active on the latter stages of virus reproduction. The results are evidence of promising compounds for further in-depth study on models in vitro and in vivo. 
Two compounds, G8 and 10S-23, inhibited the reproduction of all viruses with different efficiency. Compound G9 was active only in relation to both types of herpes. G26 suppressed reproduction of HSV-2/BH and HAdV5, whereas compounds 10S-20 and 10S-24 were active only in relation to reproduction HSV-1/US. According to the results obtained in the present study: antiviral activity of substances submitted to the post-treatments was demonstrated; the absence of antiviral activity of substances submitted to the pre-treatments, during absorption and penetration of the virus was shown; absence of virucidal activity of substances was shown. That data suggest that the substances may be active on the latter stages of virus reproduction. The results are evidence of promising compounds for further in-depth study on models in vitro and in vivo. With the aim of finding new inhibitors for this target a series of di-substituted 9,10-dihydrophenanthrene was designed as CK2 inhibitors and docked in the crystal structure of the enzyme to evaluate their ability to fit in the active site.
Design and Development of 9,10-Dihydrophenanthrene Derivatives as Inhibitors of Human Protein Kinase CK2 (A020)
The main idea was to explore if the 9,10-dihydrophenanthrene backbone is more suitable for binding than the backbone of compound 3 and to determine if the introduced functional groups can form hydrogen bonds with the amino acid residue. Some of the designed compounds were With the aim of finding new inhibitors for this target a series of di-substituted 9,10-dihydrophenanthrene was designed as CK2 inhibitors and docked in the crystal structure of the enzyme to evaluate their ability to fit in the active site. Cytotoxicity of the compounds was determined by MTT-test or neutral red dye (NR) according to standard protocols. Antiviral effect was determined using PCR, MTT-test and cytomorphological methods.
The main idea was to explore if the 9,10-dihydrophenanthrene backbone is more suitable for binding than the backbone of compound 3 and to determine if the introduced functional groups can form hydrogen bonds with the amino acid residue. Some of the designed compounds were
The main idea was to explore if the 9,10-dihydrophenanthrene backbone is more suitable for binding than the backbone of compound 3 and to determine if the introduced functional groups can form hydrogen bonds with the amino acid residue. Some of the designed compounds were synthesized and tested in vitro as well. The docking study clearly indicates that the designed compounds fit well in the ATP active site of the enzyme, and most of them were able to create hydrogen bonds with some amino acids residues. 15 of 23 synthesized and tested in vitro as well. The docking study clearly indicates that the designed compounds fit well in the ATP active site of the enzyme, and most of them were able to create hydrogen bonds with some amino acids residues. This study shows that potent CK2 inhibitors as tested can exhibit distinct effects on different tumor cell lines. Compound containing an O-prenyl residue R1 appears to be an antiproliferation agent with high activity toward MCF7 cells. In this study the human TLR4 receptor, a receptor of the innate immune system, was identified as an interaction partner of human CSN1S1 inducing expression of cytokines IL 1β, IL 6 and IL 8 in human monocytic cells concentration-and time-dependently (Vordenbäumen, S., et al. Mol. Nutr. Food Res. 2016, 60, 1079-1089) . In HEK293 cells cotransfected with TLR4 human CSN1S1 (purified from Escherichia coli) induced secretion of chemokine IL-8 secretion. In vitro flow cytometric assay confirmed CSN1S1-TLR4 receptor interaction. Chemokine sectretion as well as binding was not detected for CSN1S1 phosphorylated by protein kinase CK2 as well as denaturated CSN1S1. This supports the hypothesis, that CSN1S1 is a ligand of the TLR4 receptor exerting proinflammatory properties in phosphorylation-dependent manner. In conclusion CSN1S1 could contribute to the development of a potent immune system in breastfed offspring. 2016, 60, 1079-1089) . In HEK293 cells cotransfected with TLR4 human CSN1S1 (purified from Escherichia coli) induced secretion of chemokine IL-8 secretion. In vitro flow cytometric assay confirmed CSN1S1-TLR4 receptor interaction. Chemokine sectretion as well as binding was not detected for CSN1S1 phosphorylated by protein kinase CK2 as well as denaturated CSN1S1. This supports the hypothesis, that CSN1S1 is a ligand of the TLR4 receptor exerting proinflammatory properties in phosphorylation-dependent manner. In conclusion CSN1S1 could contribute to the development of a potent immune system in breastfed offspring.
Indeno[1,2-b]indole Inhibitors of Human Protein Kinase CK2 and Their Impact on Different Tumor Cell Lines (A021)
TLR4-Mediated Activation of Monocytes by Human αS1-Casein (A022)
A library of 69 synthetic benzenesulfonyl derivatives of heterocycles, with drug-like properties, was assayed for in vitro antiparasitic activity and the results were added to our previous report for a comprehensive SAR discussion. Seven compounds showed an IC50 between 0.25-3 µM against L. donovani and low cytotoxicity.
Compound 1-(2,3,5,6-tetramethylphenylsulfonyl)-2-methylindoline (G16), was particularly interesting, with an IC50 similar to the reference drug miltefosine. In addition, seven compounds showed an IC50 below 6 µM against T. cruzi, and three of them (E3, E9 and G3) were identified as lead scaffolds for further optimization based on their activity-toxicity profile. Furthermore, two promising structures (B15 and G15) have shown moderate inhibitory activity against P. falciparum. In general, the presence of a benzenesulfonyl moiety improves the antiparasitic activity of the heterocycles included in this study (with exception of T. b. rhodesiense) validating the criteria used in A library of 69 synthetic benzenesulfonyl derivatives of heterocycles, with drug-like properties, was assayed for in vitro antiparasitic activity and the results were added to our previous report for a comprehensive SAR discussion. Seven compounds showed an IC 50 between 0.25-3 µM against L. donovani and low cytotoxicity.
Compound 1-(2,3,5,6-tetramethylphenylsulfonyl)-2-methylindoline (G16), was particularly interesting, with an IC 50 similar to the reference drug miltefosine. In addition, seven compounds showed an IC 50 below 6 µM against T. cruzi, and three of them (E3, E9 and G3) were identified as lead scaffolds for further optimization based on their activity-toxicity profile. Furthermore, two promising structures (B15 and G15) have shown moderate inhibitory activity against P. falciparum. In general, the presence of a benzenesulfonyl moiety improves the antiparasitic activity of the heterocycles included in this study (with exception of T. b. rhodesiense) validating the criteria used in the selection of the fragment-based drug design approach. Finally, from the SAR analysis it could be concluded that the presence of electron withdrawing and lipophilic groups were favorable for the antiparasitic activity.
Pharmaceuticals 2017, 10, 20 17 of 23 the selection of the fragment-based drug design approach. Finally, from the SAR analysis it could be concluded that the presence of electron withdrawing and lipophilic groups were favorable for the antiparasitic activity.
This investigation showed influence of five new Pt(IV) complexes on 16 strains of bacteria. Antibacterial activity was tested using microdilution method with resazurin while antibiofilm activity was observed by tissue culture plate method and antibiotic doxycycline was used as positive control. The results were expressed as minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and biofilm inhibitory concentration (BIC). The complexes were labeled from C1 to C5. The best result on Gram positive bacteria was obtained with C1 and MIC on Staphylococcus aureus ˂ ATCC 25923 was 7.81 µg/mL. Bifidobacterium animalis subsp. lactis (probiotic) was sensitive to C2 (MIC at 15.625 µg/mL). The best sensitivity on Gram negative bacteria was observed on Escherichia coli ATCC 25922 with C1, C2, C3 and C4, on Proteus mirabilis ATCC 12453 with C1, and on Pseudomonas aeruginosa with C2, C3 and C5 (all MICs at 250 µg/mL). The tested complexes were more efficient as antibiofilm agents and the best results were obtained with C2 acting against S. aureus and S. aureus ATCC 25923 biofilm. In conclusion, we noticed that the tested compounds exhibited promising properties as antibacterial agents and antibiofilm agents. Tilorone (amixin, dihydrochloride 2,7-bis[2-(diethylamino)ethoxy] fluorenone-9) is a low molecular interferon inducer that is effective against a wide range of viral infections including herpes viruses. The mechanism of tilorone antiviral action is associated with inhibition of virus-specific peptides translation in infected cells resulting in the suppression of virus replication. An appropriate therapy of the viral infections with external rash besides the systemic preparations must include topical drugs that will reduce clinical signs of infection, improve skin epithelialization, and decrease time of virus elimination. Considering this, we developed a new topical antiviral 2% tilorone preparation in the form of ointment.
The aim of investigation was to study the parameters of acute toxicity of the 2% tilorone ointment. In accordance with the requirements of the European Pharmacopoeia 8.0 the acute toxicity of the developed ointment was studied using two methods-intragastric administration and cutaneous application. All animals were treated in compliance with the
Acute intragastric toxicity was carried out in two species of rodents [54 white outbred mice (20-25 g) and 27 white Vistar rats (200-220 g)] that were given intragastrically an aqueous solution of ointment at a dose of 0.5 g/kg. Acute dermal toxicity was studied in 27 white outbred mice (20-25 g); the application area was 5.5-6.0 cm 2 .
The animals were monitored daily for clinical signs (breathing, physical activity, convulsions, analgesia, muscle tone, ophthalmic, cardiovascular and gastrointestinal symptoms, diuresis, skin signs) in the course of 14 days. All the animals remained alive and active; the distinctive symptoms of intoxication were absent. It was also determined that an effective dose of 2% test ointment does not cause toxic effects on human body is DL 0 ≤ 0.4 g/kg. In our laboratory, we focus on the design, synthesis, and evaluation of fluorinated compounds that could be used in the treatment of diseases caused by the Epstein-Barr virus (EBV) and virus vesicular stomatitis (VVS) (Peng L., et al. J. Fluor. Chem. 2008, 29, 743-766) . We used the model of DNA and RNA viruses, which are characterized by acute and latent clinical form of the disease.
For this purpose, in a first step, we used the PASS software by which we could identify potential antiviral candidates among which a fluorinated derivative of uracil (G27), a trifluoromethyl-substituted derivative of a thiosugar (SBIO6), a bisphosphonic acid (10s19) and several derivatives of alanin and glucose (10s20-10s28) (Lagunin A., et al. Bioinformatics 2000, 16, 747-748). Our in vitro studies revealed an antiviral activity for a few compounds. A real time polymerase chain reaction (PCR) assay was performed to assess the antiviral activity of various drugs against EBV. The MTT-assay was used for detection anti-VVS activity. Three compounds appeared to be effective against EBV: G27 (EC50 = 100 µg/mL), 10s20 (EC50 = 1 µg/mL), and 10s25 (EC50 < 62 µg/mL, replication of EBV was suppressed at 100% at a concentration of 62 µg/mL). The ability to inhibit reproduction of VVS was shown for compound 10s19 (EC50 = 19 µg/mL) and for compound 10s24 (EC50 = 29 µg/mL). It was established that the selectivity indices of these compounds ranged from 10 to 100.
As Epstein-Barr virus (EBV) is the cause of several lymphoproliferative diseases, we studied the apoptosis induction potency of compounds G27 and SBIO6 (Novalic Zlata, et al., Med. Chem. 2016, 6, 449-466). Apoptotic cells were detected using a flow cytometry (Riccardi C., et al. Nat. Protoc. 2006, 1,  1458-1461 ). The sub-G1 peak was measured with a Epics XL flow cytometer (Beckman Coulter, Brea, CA, USA) and analyzed using Flowing Software, version 2.5. Addition of G27 led to the observation of two peaks in the histogram, what may indicate a break of the cell cycle by this compound. It was also established that by addition of SBIO6 the percentage of apoptotic cells was significantly increased when compared to the control and reached 70%-90%. The obtained data let us regard these compounds as perspective antiviral and antitumor agents. Combination of predictive analysis with in vitro studies allows to evaluate the biological properties of compounds and to discover the mechanism of their action. Our in vitro studies revealed an antiviral activity for a few compounds. A real time polymerase chain reaction (PCR) assay was performed to assess the antiviral activity of various drugs against EBV. The MTT-assay was used for detection anti-VVS activity. Three compounds appeared to be effective against EBV: G27 (EC50 = 100 µg/mL), 10s20 (EC50 = 1 µg/mL), and 10s25 (EC50 < 62 µg/mL, replication of EBV was suppressed at 100% at a concentration of 62 µg/mL). The ability to inhibit reproduction of VVS was shown for compound 10s19 (EC50 = 19 µg/mL) and for compound 10s24 (EC50 = 29 µg/mL). It was established that the selectivity indices of these compounds ranged from 10 to 100.
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As Epstein-Barr virus (EBV) is the cause of several lymphoproliferative diseases, we studied the apoptosis induction potency of compounds G27 and SBIO6 (Novalic Zlata, et al., Med. Chem. 2016, 6, 449-466). Apoptotic cells were detected using a flow cytometry (Riccardi C., et al. Nat. Protoc. 2006, 1, 1458-1461). The sub-G1 peak was measured with a Epics XL flow cytometer (Beckman Coulter, Brea, CA, USA) and analyzed using Flowing Software, version 2.5. Addition of G27 led to the observation of two peaks in the histogram, what may indicate a break of the cell cycle by this compound. It was also established that by addition of SBIO6 the percentage of apoptotic cells was significantly increased when compared to the control and reached 70%-90%. The obtained data let us regard these compounds as perspective antiviral and antitumor agents. Combination of predictive analysis with in vitro studies allows to evaluate the biological properties of compounds and to discover the mechanism of their action. Our in vitro studies revealed an antiviral activity for a few compounds. A real time polymerase chain reaction (PCR) assay was performed to assess the antiviral activity of various drugs against EBV. The MTT-assay was used for detection anti-VVS activity. Three compounds appeared to be effective against EBV: G27 (EC50 = 100 µg/mL), 10s20 (EC50 = 1 µg/mL), and 10s25 (EC50 < 62 µg/mL, replication of EBV was suppressed at 100% at a concentration of 62 µg/mL). The ability to inhibit reproduction of VVS was shown for compound 10s19 (EC50 = 19 µg/mL) and for compound 10s24 (EC50 = 29 µg/mL). It was established that the selectivity indices of these compounds ranged from 10 to 100.
As Epstein-Barr virus (EBV) is the cause of several lymphoproliferative diseases, we studied the apoptosis induction potency of compounds G27 and SBIO6 (Novalic Zlata, et al., Med. Chem. 2016, 6, 449-466). Apoptotic cells were detected using a flow cytometry (Riccardi C., et al. Nat. Protoc. 2006, 1, 1458-1461). The sub-G1 peak was measured with a Epics XL flow cytometer (Beckman Coulter, Brea, CA, USA) and analyzed using Flowing Software, version 2.5. Addition of G27 led to the observation of two peaks in the histogram, what may indicate a break of the cell cycle by this compound. It was also established that by addition of SBIO6 the percentage of apoptotic cells was significantly increased when compared to the control and reached 70%-90%. The obtained data let us regard these compounds as perspective antiviral and antitumor agents. Combination of predictive analysis with in vitro studies allows to evaluate the biological properties of compounds and to discover the mechanism of their action. Our in vitro studies revealed an antiviral activity for a few compounds. A real time polymerase chain reaction (PCR) assay was performed to assess the antiviral activity of various drugs against EBV. The MTT-assay was used for detection anti-VVS activity. Three compounds appeared to be effective against EBV: G27 (EC 50 = 100 µg/mL), 10s20 (EC 50 = 1 µg/mL), and 10s25 (EC 50 < 62 µg/mL, replication of EBV was suppressed at 100% at a concentration of 62 µg/mL). The ability to inhibit reproduction of VVS was shown for compound 10s19 (EC 50 = 19 µg/mL) and for compound 10s24 (EC 50 = 29 µg/mL). It was established that the selectivity indices of these compounds ranged from 10 to 100.
As Epstein-Barr virus (EBV) is the cause of several lymphoproliferative diseases, we studied the apoptosis induction potency of compounds G27 and SBIO6 (Novalic Zlata, et al., Med. Chem. 2016, 6, 449-466). Apoptotic cells were detected using a flow cytometry (Riccardi C., et al. Nat. Protoc. 2006, 1, 1458-1461). The sub-G1 peak was measured with a Epics XL flow cytometer (Beckman Coulter, Brea, CA, USA) and analyzed using Flowing Software, version 2.5. Addition of G27 led to the observation of two peaks in the histogram, what may indicate a break of the cell cycle by this compound. It was also established that by addition of SBIO6 the percentage of apoptotic cells was significantly increased when compared to the control and reached 70%-90%. The obtained data let us regard these compounds as perspective antiviral and antitumor agents. Combination of predictive analysis with in vitro studies allows to evaluate the biological properties of compounds and to discover the mechanism of their action. Target A series of 22 synthetic drug-like hydantoin derivatives, including aryl or alkenyl 5,5-disubstituted hydantoins, spirohydantoins and annulated bicyclic and tricyclic hydantoins, was assayed for in vitro antibacterial and antifungal activity. The antimicrobial activity was tested by determination of the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) using microdilution method. The tested hydantoin derivatives showed moderate antibacterial and weak antifungal activity. The intensity of acting varied depending on the structure and concentration of the test substances and the type of test organisms. The bicyclic benzeneselenenyl derivatives of hydantoin have shown the highest inhibitory activity. The tested compounds appear promising for a fragment-based drug design approach and further bioactivity studies. The developed predictive model was used to design new peptides. Antimicrobial potency of these peptides has been evaluated by in vitro testing of peptides' activity against different bacteria (including drug resistant strains). In vitro estimation shows high accuracy of the developed predictive model.
Heat Shock Proteins in
Antimicrobial Activity of Various Hydantoin Derivatives (A032)
Ivana D. Radojević, Marijana V. Đukić, Ljiljana R. Čomić, Darko P. Ašanin, Biljana M. Šmit * Faculty of Science, University of Kragujevac, Radoja Domanovića 12, 34000 Kragujevac, Serbia * Correspondence: biljam@kg.ac.rs A series of 22 synthetic drug-like hydantoin derivatives, including aryl or alkenyl 5,5-disubstituted hydantoins, spirohydantoins and annulated bicyclic and tricyclic hydantoins, was assayed for in vitro antibacterial and antifungal activity. The antimicrobial activity was tested by determination of the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) using microdilution method. The tested hydantoin derivatives showed moderate antibacterial and weak antifungal activity. The intensity of acting varied depending on the structure and concentration of the test substances and the type of test organisms. The bicyclic benzeneselenenyl derivatives of hydantoin have shown the highest inhibitory activity. The tested compounds appear promising for a fragment-based drug design approach and further bioactivity studies.
The chemistry of pyridazinones has been an interesting field of study for decades. The synthesis of novel pyridazinone derivatives and investigation of their chemical and biological behavior have gained more importance in recent decades for biological, medicinal, and agricultural reason. Living organisms finds it difficult to construct N-N bonds, which limits the natural abundance of compounds having such bonds. The pharmacological activity of 4,5-dihydro-6-phenyl-3(2H)-pyridazinones has been extensively studied and they are known for their cardiovascular effects. In this field several compounds such as zardaverine or imazodan have been developed as PDE III inhibitors in the search for new antiplatelet or cardiotonic agents. A number of 6-(substituted-phenyl)-2-(4-substitutedphenyl-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4,5-dihydropyridazin-3(2H)-one derivatives were designed and synthesized by a sequence of reactions starting from the respective aryl hydrocarbons. The final compounds 4a-4u were evaluated for antihypertensive activities by the non-invasive Tail Cuff method. The compounds 4e, 4i and 4k showed appreciable antihypertensive activity comparable with that of standard hydralazine and propranolol. 
